Biotech Bullish Stocks: Merrimack Pharmaceuticals (NASDAQ:MACK), Sarepta Therapeutics (NASDAQ:SRPT), Northwest Biotherapeutics (NASDAQ:NWBO), Progenics Pharmaceuticals (NASDAQ:PGNX)

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that it will present at the 2014 AACR Annual Meeting. The conference will take place on April 5-9, 2014 at the San Diego Convention Center in San Diego. Presentations will include a clinical pilot study evaluating the feasibility of using ferumoxytol* as an MRI imaging agent prior to MM-398 investigational treatment. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stock performance was 6.15% in … Continue reading Biotech Bullish Stocks: Merrimack Pharmaceuticals (NASDAQ:MACK), Sarepta Therapeutics (NASDAQ:SRPT), Northwest Biotherapeutics (NASDAQ:NWBO), Progenics Pharmaceuticals (NASDAQ:PGNX)

Small Cap Active Runners: IAMGOLD (NYSE:IAG), Trina Solar (NYSE:TSL), AK Steel Holding Corporation (NYSE:AKS), The Medicines Company (NASDAQ:MDCO)

IAMGOLD Corporation (USA) (NYSE:IAG) announced that a Form 40-F report has been filed with the U.S. Securities and Exchange Commission, consisting of the 2013 annual audited financial statements, management discussion and analysis and the annual information form (‘AIF”). IAMGOLD Corp (USA) (NYSE:IAG) stock performance was -2.27% in last session and finished the day at $3.44. Traded volume was 5.83million shares in the last session and … Continue reading Small Cap Active Runners: IAMGOLD (NYSE:IAG), Trina Solar (NYSE:TSL), AK Steel Holding Corporation (NYSE:AKS), The Medicines Company (NASDAQ:MDCO)

Cara Therapeutics Inc (NASDAQ:CARA) posted its quarterly earnings results on Thursday. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by $0.31. Cara Therapeutics Inc (NASDAQ:CARA) stock performance was 3.44% in last session and finished the day at $19.25. Traded volume was 234.6K shares in the last session and the average volume of the stock remained 298.33K … Continue reading Biotech Most Volatile: Cara Therapeutics Inc (NASDAQ:CARA), Prothena Corporation (NASDAQ:PRTA), CorMedix Inc. (NYSEMKT:CRMD), Stemline Therapeutics (NASDAQ:STML)

On March 12, 2014, Recro Pharma, Inc (NASDAQ:REPH) completed its initial public offering (“IPO”). In relation to such IPO, the Company filed information reflected in a slide presentation as a free writing prospectus on February 13, 2014. Recro Pharma Inc (NASDAQ:REPH) stock performance was -4.64% in last session and finished the day at $6.98. Traded volume was 43.6K shares in the last session and the … Continue reading Biotech New Lows: Recro Pharma (NASDAQ:REPH), Ruthigen (NASDAQ:RTGN), Mediwound (NASDAQ:MDWD), Dicerna Pharmaceuticals (NASDAQ:DRNA)

Apple Inc. (NASDAQ:AAPL) and Samsung return to federal court on Tuesday for opening statements in their latest patent battle, with the iPhone maker expected to present more detailed evidence in its attempt to win a US ban on sales of several Samsung smartphones. Apple Inc. (NASDAQ:AAPL) and Samsung Electronics Co Ltd have been litigating around the world for nearly three years. Apple Inc. (NASDAQ:AAPL) stock … Continue reading Investor’s Alert: Apple Inc. (NASDAQ:AAPL), Nokia Corporation (ADR) (NYSE:NOK), Tesla Motors Inc (NASDAQ:TSLA), Baidu Inc (ADR) (NASDAQ:BIDU)

Dyax Corp. (NASDAQ:DYAX) was a big mover last session, as the company saw its shares rise nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. Dyax Corp. (NASDAQ:DYAX) currently has a Zacks Rank #3 (Hold). Dyax Corp. (NASDAQ:DYAX) stock performance was 5.90% in last session and finished the day … Continue reading Healthcare Bullish Stocks: Dyax Corp. (NASDAQ:DYAX), Incyte Corporation (NASDAQ:INCY), ISIS Pharmaceuticals (NASDAQ:ISIS), NPS Pharmaceuticals (NASDAQ:NPSP)